We just received data on a new analyst forecast for $VRNS. Matthew Hedberg from RBC Capital set a price target of 41.0 for VRNS.
To track analyst ratings and price targets for $VRNS, check out Quiver Quantitative's $VRNS forecast page.
Should you buy $VRNS?
Some analysts are better than others. To view the past performance of RBC Capital, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$VRNS Price Targets
Multiple analysts have issued price targets for $VRNS recently. We have seen 19 analysts offer price targets for $VRNS in the last 6 months, with a median target of $60.0.
Here are some recent targets:
- Rob Owens from Piper Sandler set a target price of $47.0 on 01/05/2026
- Matthew Hedberg from RBC Capital set a target price of $41.0 on 01/05/2026
- Saket Kalia from Barclays set a target price of $45.0 on 01/05/2026
- Todd Weller from Stephens & Co. set a target price of $40.0 on 12/30/2025
- Fatima Boolani from Citigroup set a target price of $40.0 on 11/03/2025
- Shyam Patil from Susquehanna set a target price of $50.0 on 10/29/2025
- Junaid Siddiqui from Truist Securities set a target price of $50.0 on 10/29/2025
$VRNS Insider Trading Activity
$VRNS insiders have traded $VRNS stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $VRNS stock by insiders over the last 6 months:
- GUY MELAMED (CFO and COO) has made 0 purchases and 5 sales selling 110,386 shares for an estimated $6,264,165.
- DEN BOSCH FRED VAN sold 3,000 shares for an estimated $165,240
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNS Revenue
$VRNS had revenues of $161.6M in Q3 2025. This is an increase of 9.12% from the same period in the prior year.
You can track VRNS financials on Quiver Quantitative's VRNS stock page.
$VRNS Hedge Fund Activity
We have seen 185 institutional investors add shares of $VRNS stock to their portfolio, and 150 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. removed 2,113,314 shares (-96.2%) from their portfolio in Q3 2025, for an estimated $121,452,155
- CADIAN CAPITAL MANAGEMENT, LP added 1,816,100 shares (+inf%) to their portfolio in Q3 2025, for an estimated $104,371,267
- FULLER & THALER ASSET MANAGEMENT, INC. added 1,286,079 shares (+inf%) to their portfolio in Q3 2025, for an estimated $73,910,960
- GREENVALE CAPITAL LLP added 1,275,000 shares (+283.3%) to their portfolio in Q3 2025, for an estimated $73,274,250
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,031,762 shares (+inf%) to their portfolio in Q3 2025, for an estimated $59,295,362
- CLAL INSURANCE ENTERPRISES HOLDINGS LTD added 850,000 shares (+166.7%) to their portfolio in Q3 2025, for an estimated $48,849,500
- GOLDMAN SACHS GROUP INC removed 836,008 shares (-22.0%) from their portfolio in Q3 2025, for an estimated $48,045,379
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
